Citations 1
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers
Weinberg, David S. , Foster, Nathan R. , Della’Zanna, Gary , Pallotto, Angela, Katz, Leo C., Henry, Christopher , Moleski, Stephanie , McMurray, Ryan P. , Limburg, Paul J. , Waldman, Scott A , Kraft, Walter K. , Kastenberg, David , Waldman, Scott A.
Cancer Biology & Therapy | October 11, 2021 | Volume: 22 | Issue: 10-12 | Pages: 544-553
